Together they will cover recent relocation projects, the benefits of Triangle Park in North Carolina and the all important $1bn Investment Novartis has made in the region, to develop their first cell culture-derived influenza vaccine manufacturing plant in the US.
The webinar will address questions and issues concerning the location process applicable to any company at any stage in development.
The webinar will also address issues related to factors that are important to consider when locating in the US; importance of an available and trained workforce; infrastructure; R&D capabilities; funding and capital availability; as well as a supportive community surrounding the life sciences and quality of life.
Frost & Sullivan and North Carolina Biotechnology Centre are the content developers for the webinar.